BiotechTube
Home/Senseonics/Edward J. Fiorentino
EJ

Edward J. Fiorentino

Board Director

Senseonics

Roles

Board DirectoratSenseonics
Executive ChairmanatTerSera Therapeutics

Therapeutic Areas

DiabetesMetabolic Health

Senseonics Pipeline

DrugIndicationPhase
Eversense E3 / XL (180-day)Continuous Glucose Monitoring for DiabetesFDA PMA Approved
Eversense 365-day SystemContinuous Glucose Monitoring for DiabetesCE Mark Approved
Next-Generation CGM SystemContinuous Glucose Monitoring for DiabetesResearch & Development

Leadership Team at Senseonics

TT
Timothy T. Goodnow, PhD
President & Chief Executive Officer
MJ
Mukul Jain, PhD
Chief Operating Officer
FR
Francine R. Kaufman, M.D.
Chief Medical Officer
SP
Stephen P. DeFalco
Chairman of the Board
View full Senseonics profile